1
|
Morris C, Lee YS, Yoon S. Adventitious agent detection methods in bio-pharmaceutical applications with a focus on viruses, bacteria, and mycoplasma. Curr Opin Biotechnol 2021; 71:105-114. [PMID: 34325176 DOI: 10.1016/j.copbio.2021.06.027] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 06/22/2021] [Accepted: 06/29/2021] [Indexed: 10/20/2022]
Abstract
Adventitious agents present significant complications to biopharmaceutical manufacturing. Adventitious agents include numerous lifeforms such as bacteria, fungi, viruses, mycoplasma, and others that are inadvertently introduced into biological systems. They present significant problems to the stability of cell cultures and the sterility of manufacturing products. In this review, detection methods for bacteria, viruses, and mycoplasma are comprehensively addressed. Detection methods for viruses include traditional culture-based methods, electron microscopy studies, in vitro molecular and antibody assays, sequencing methods (massive parallel or next generation sequencing), and degenerate PCR (polymerase chain reaction). Bacteria, on the other hand, can be detected with culture-based approaches, PCR, and biosensor-based methods. Mycoplasma can be detected via PCR (including specific kits), microbiological culture methods, and enzyme-linked immunosorbent assays (ELISA). This review highlights the advantages and weaknesses of current detection methods while exploring potential avenues for further development and improvement of novel detection methods. Additionally, a brief evaluation of the transition of these methods into the gene therapy production realm with a focus on viral titer monitoring will be presented.
Collapse
Affiliation(s)
- Caitlin Morris
- Pharmaceutical Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA
| | - Yong Suk Lee
- Pharmaceutical Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA
| | - Seongkyu Yoon
- Chemical Engineering, University of Massachusetts Lowell, Lowell, MA 01854, USA.
| |
Collapse
|
2
|
Towards dynamic monitoring of cell cultures using high throughput sequencing. Vaccine 2019; 37:1001-1005. [DOI: 10.1016/j.vaccine.2018.12.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Revised: 12/04/2018] [Accepted: 12/09/2018] [Indexed: 11/23/2022]
|
3
|
Lambert C, Braxton C, Charlebois RL, Deyati A, Duncan P, La Neve F, Malicki HD, Ribrioux S, Rozelle DK, Michaels B, Sun W, Yang Z, Khan AS. Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection. Viruses 2018; 10:E528. [PMID: 30262776 PMCID: PMC6213042 DOI: 10.3390/v10100528] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Revised: 09/19/2018] [Accepted: 09/25/2018] [Indexed: 02/07/2023] Open
Abstract
High-throughput sequencing (HTS) has demonstrated capabilities for broad virus detection based upon discovery of known and novel viruses in a variety of samples, including clinical, environmental, and biological. An important goal for HTS applications in biologics is to establish parameter settings that can afford adequate sensitivity at an acceptable computational cost (computation time, computer memory, storage, expense or/and efficiency), at critical steps in the bioinformatics pipeline, including initial data quality assessment, trimming/cleaning, and assembly (to reduce data volume and increase likelihood of appropriate sequence identification). Additionally, the quality and reliability of the results depend on the availability of a complete and curated viral database for obtaining accurate results; selection of sequence alignment programs and their configuration, that retains specificity for broad virus detection with reduced false-positive signals; removal of host sequences without loss of endogenous viral sequences of interest; and use of a meaningful reporting format, which can retain critical information of the analysis for presentation of readily interpretable data and actionable results. Furthermore, after alignment, both automated and manual evaluation may be needed to verify the results and help assign a potential risk level to residual, unmapped reads. We hope that the collective considerations discussed in this paper aid toward optimization of data analysis pipelines for virus detection by HTS.
Collapse
Affiliation(s)
| | | | - Robert L Charlebois
- Analytical Research and Development, Sanofi Pasteur, Toronto, ON M2R 3T4, Canada.
| | | | - Paul Duncan
- Merck & Co. Inc., West Point, PA 19486, USA.
| | | | | | | | | | - Brandye Michaels
- Analytical Research and Development: Microbiology, Pfizer Inc., Andover, MA 01810, USA.
| | | | - Zhihui Yang
- Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD 20708, USA.
| | - Arifa S Khan
- Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
| |
Collapse
|
4
|
Khan AS, Benetti L, Blumel J, Deforce D, Egan WM, Knezevic I, Krause PR, Mallet L, Mayer D, Minor PD, Neels P, Wang G. Report of the international conference on next generation sequencing for adventitious virus detection in biologicals. Biologicals 2018; 55:1-16. [DOI: 10.1016/j.biologicals.2018.08.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2018] [Accepted: 08/02/2018] [Indexed: 01/06/2023] Open
|
5
|
Geisler C. A new approach for detecting adventitious viruses shows Sf-rhabdovirus-negative Sf-RVN cells are suitable for safe biologicals production. BMC Biotechnol 2018; 18:8. [PMID: 29415704 PMCID: PMC5803895 DOI: 10.1186/s12896-017-0412-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Accepted: 12/28/2017] [Indexed: 01/01/2023] Open
Abstract
Background Adventitious viral contamination in cell substrates used for biologicals production is a major safety concern. A powerful new approach that can be used to identify adventitious viruses is a combination of bioinformatics tools with massively parallel sequencing technology. Typically, this involves mapping or BLASTN searching individual reads against viral nucleotide databases. Although extremely sensitive for known viruses, this approach can easily miss viruses that are too dissimilar to viruses in the database. Moreover, it is computationally intensive and requires reference cell genome databases. To avoid these drawbacks, we set out to develop an alternative approach. We reasoned that searching genome and transcriptome assemblies for adventitious viral contaminants using TBLASTN with a compact viral protein database covering extant viral diversity as the query could be fast and sensitive without a requirement for high performance computing hardware. Results We tested our approach on Spodoptera frugiperda Sf-RVN, a recently isolated insect cell line, to determine if it was contaminated with one or more adventitious viruses. We used Illumina reads to assemble the Sf-RVN genome and transcriptome and searched them for adventitious viral contaminants using TBLASTN with our viral protein database. We found no evidence of viral contamination, which was substantiated by the fact that our searches otherwise identified diverse sequences encoding virus-like proteins. These sequences included Maverick, R1 LINE, and errantivirus transposons, all of which are common in insect genomes. We also identified previously described as well as novel endogenous viral elements similar to ORFs encoded by diverse insect viruses. Conclusions Our results demonstrate TBLASTN searching massively parallel sequencing (MPS) assemblies with a compact, manually curated viral protein database is more sensitive for adventitious virus detection than BLASTN, as we identified various sequences that encoded virus-like proteins, but had no similarity to viral sequences at the nucleotide level. Moreover, searches were fast without requiring high performance computing hardware. Our study also documents the enhanced biosafety profile of Sf-RVN as compared to other Sf cell lines, and supports the notion that Sf-RVN is highly suitable for the production of safe biologicals. Electronic supplementary material The online version of this article (doi: 10.1186/s12896-017-0412-z) contains supplementary material, which is available to authorized users.
Collapse
|
6
|
Carvalho SB, Freire JM, Moleirinho MG, Monteiro F, Gaspar D, Castanho MARB, Carrondo MJT, Alves PM, Bernardes GJL, Peixoto C. Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles. Bioconjug Chem 2016; 27:2386-2399. [PMID: 27652605 PMCID: PMC5080633 DOI: 10.1021/acs.bioconjchem.6b00372] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
![]()
Virus-like
particles (VLPs) constitute a promising platform in
vaccine development and targeted drug delivery. To date, most applications
use simple nonenveloped VLPs as human papillomavirus or hepatitis
B vaccines, even though the envelope is known to be critical to retain
the native protein folding and biological function. Here, we present
tagged enveloped VLPs (TagE-VLPs) as a valuable strategy for the downstream
processing and monitoring of the in vivo production of specific-site-functionalized
enveloped influenza VLPs. This two-step procedure allows bioorthogonal
functionalization of azide-tagged nascent influenza type A hemagglutinin
proteins in the envelope of VLPs through a strain-promoted [3 + 2]
alkyne–azide cycloaddition reaction. Importantly, labeling
does not influence VLP production and allows for construction of functionalized
VLPs without deleterious effects on their biological function. Refined
discrimination and separation between VLP and baculovirus, the major
impurity of the process, is achieved when this technique is combined
with flow cytometry analysis, as demonstrated by atomic force microscopy.
TagE-VLPs is a versatile tool broadly applicable to the production,
monitoring, and purification of functionalized enveloped VLPs for
vaccine design trial runs, targeted drug delivery, and molecular imaging.
Collapse
Affiliation(s)
- Sofia B Carvalho
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa , Avenida da República, 2780-157 Oeiras, Portugal.,iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal
| | - João M Freire
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal
| | - Mafalda G Moleirinho
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa , Avenida da República, 2780-157 Oeiras, Portugal.,iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal
| | - Francisca Monteiro
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa , Avenida da República, 2780-157 Oeiras, Portugal.,iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal
| | - Diana Gaspar
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal
| | - Miguel A R B Castanho
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal
| | - Manuel J T Carrondo
- iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal.,Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa , 2829-516 Monte da Caparica, Portugal
| | - Paula M Alves
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa , Avenida da República, 2780-157 Oeiras, Portugal.,iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal
| | - Gonçalo J L Bernardes
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.,Department of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, United Kingdom
| | - Cristina Peixoto
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa , Avenida da República, 2780-157 Oeiras, Portugal.,iBET, Instituto de Biologia Experimental e Tecnológica , Apartado 12, 2780-901 Oeiras, Portugal
| |
Collapse
|
7
|
Johnson SA, Brown MR, Lute SC, Brorson KA. Adapting viral safety assurance strategies to continuous processing of biological products. Biotechnol Bioeng 2016; 114:21-32. [DOI: 10.1002/bit.26060] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2016] [Revised: 07/21/2016] [Accepted: 07/26/2016] [Indexed: 01/18/2023]
Affiliation(s)
- Sarah A. Johnson
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland 20993
| | - Matthew R. Brown
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland 20993
| | - Scott C. Lute
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland 20993
| | - Kurt A. Brorson
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland 20993
| |
Collapse
|
8
|
Rhabdovirus-like endogenous viral elements in the genome of Spodoptera frugiperda insect cells are actively transcribed: Implications for adventitious virus detection. Biologicals 2016; 44:219-225. [PMID: 27236849 DOI: 10.1016/j.biologicals.2016.04.004] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Revised: 04/06/2016] [Accepted: 04/11/2016] [Indexed: 11/21/2022] Open
Abstract
Spodoptera frugiperda (Sf) cell lines are used to produce several biologicals for human and veterinary use. Recently, it was discovered that all tested Sf cell lines are persistently infected with Sf-rhabdovirus, a novel rhabdovirus. As part of an effort to search for other adventitious viruses, we searched the Sf cell genome and transcriptome for sequences related to Sf-rhabdovirus. To our surprise, we found intact Sf-rhabdovirus N- and P-like ORFs, and partial Sf-rhabdovirus G- and L-like ORFs. The transcribed and genomic sequences matched, indicating the transcripts were derived from the genomic sequences. These appear to be endogenous viral elements (EVEs), which result from the integration of partial viral genetic material into the host cell genome. It is theoretically impossible for the Sf-rhabdovirus-like EVEs to produce infectious virus particles as 1) they are disseminated across 4 genomic loci, 2) the G and L ORFs are incomplete, and 3) the M ORF is missing. Our finding of transcribed virus-like sequences in Sf cells underscores that MPS-based searches for adventitious viruses in cell substrates used to manufacture biologics should take into account both genomic and transcribed sequences to facilitate the identification of transcribed EVE's, and to avoid false positive detection of replication-competent adventitious viruses.
Collapse
|
9
|
Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing. Vaccine 2015; 34:2035-43. [PMID: 26709640 PMCID: PMC4823300 DOI: 10.1016/j.vaccine.2015.12.020] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2015] [Revised: 11/30/2015] [Accepted: 12/05/2015] [Indexed: 02/05/2023]
Abstract
Deep sequencing has potential as an improved adventitious virus screening method. 15 laboratories sequenced a common reagent containing 25 target viruses. 6 viruses were detected by all lab, the remainder were detected by 4–14 labs. A wide range of sample preparation and bioinformatics methods is currently used. A common reference material is essential to enable results to be compared.
Background Unbiased deep sequencing offers the potential for improved adventitious virus screening in vaccines and biotherapeutics. Successful implementation of such assays will require appropriate control materials to confirm assay performance and sensitivity. Methods A common reference material containing 25 target viruses was produced and 16 laboratories were invited to process it using their preferred adventitious virus detection assay. Results Fifteen laboratories returned results, obtained using a wide range of wet-lab and informatics methods. Six of 25 target viruses were detected by all laboratories, with the remaining viruses detected by 4–14 laboratories. Six non-target viruses were detected by three or more laboratories. Conclusion The study demonstrated that a wide range of methods are currently used for adventitious virus detection screening in biological products by deep sequencing and that they can yield significantly different results. This underscores the need for common reference materials to ensure satisfactory assay performance and enable comparisons between laboratories.
Collapse
|